Shay Capital LLC Silence Therapeutics PLC Transaction History

Shay Capital LLC

$606 Million
Q1 2025

A detailed history of Shay Capital LLC transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Shay Capital LLC holds 47,728 shares of SLN stock, worth $231,480. This represents 0.02% of its overall portfolio holdings.

Number of Shares

47,728

Holding current value

$231,480

% of portfolio

0.02%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2025 May 15, 2025	BUY	$2.82 - $7.41 $134,592 - $353,664	47,728 New	47,728 $134,000
Q1 2024 May 15, 2024	BUY	$17.39 - $26.25 $263,458 - $397,687	15,150 New	15,150 $327,000

Others Institutions Holding SLN

# of Institutions

Shares Held

22.7M

Call Options Held

1.3K

Put Options Held

2.6K

Tcg Crossover Management, LLC Palo Alto, CA

3.03M
Shares

$14.7 Million
2.06% of portfolio
Siren, L.L.C. New York, NY

2.79M
Shares

$13.5 Million
0.45% of portfolio
Redmile Group, LLC San Francisco, CA

2.21M
Shares

$10.7 Million
0.66% of portfolio
Morgan Stanley New York, NY

2M
Shares

$9.7 Million
0.0% of portfolio
Lombard Odier Asset Management (Usa) Corp New York, NY

1.85M
Shares

$8.97 Million
0.44% of portfolio

View Full List

About Silence Therapeutics plc

Ticker SLN
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,888,400
Market Cap $174M
Description
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...

More about SLN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shay Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shay Capital LLC with notifications on news.

Account